Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2005

View Archived Issues

Spotlight on neuroprotective agents

Sirna and Massachusetts General Hospital to test siRNAs in hearing restoration

PEGylated dipetarudin displays enhanced pharmacokinetics

In vitro data demonstrate the genetic targets of SKI-606

New data on the effects and safety of FTY-720 presented

New data on the weight-lowering effects of pramlintide in obesity

SPRC-AB01 reported effective in chronic rhinosinusitis

Becocalcidiol improves symptoms of mild to moderate psoriasis

Dynavax's hepatitis B vaccine induces good protective response in older subjects

Ezetimibe improves the lipid profile of patients with renal disorders

Effective control of serum phosphorus levels with lanthanum carbonate in hemodialysis patients

AC-162352 shows promise in the treatment of obesity

New therapeutic agents for osteoporosis reported by Merck Frosst

Antigenic SARS polypeptides disclosed in Vaxim patent

New Japanese study to evaluate combination treatment for pancreatic cancer

BMS-068645 pharmacologic stress agent enters phase III

7TM Pharma and Ortho-McNeil team up in asthma and allergy

Cephalon completes acquisition of Salmedix

DNAVEC to codevelop Alzheimer's disease nasal spray vaccine

Kuhnil expands development of nimotuzumab to Korea

Fabre-Kramer reacquires Gepirone ER rights from Organon

Angiomax labeling expanded to include REPLACE-2 data in PCI

FDA approves Xeloda for adjuvant treatment of colon cancer

Pfizer to acquire Vicuron

Tygacil receives FDA approval

Alinia approved for use in adults

Enrollment suspended in ASSENT 4 PCI study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026